Objective To develop a new evidence‐based, pharmacologic treatment guideline for rheumatoid
arthritis (RA). Methods We conducted systematic reviews to synthesize the evidence for …

The American College of Rheumatology (ACR) most recently published recommendations
for the use of diseasemodifying antirheumatic drugs (DMARDs) and biologic agents in the …

Objective Although the systematic measurement of disease activity facilitates clinical
decision making in rheumatoid arthritis (RA), no recommendations currently exist on which …

Guidelines and recommendations developed and/or endorsed by the American College of
Rheumatology (ACR) are intended to provide guidance for particular patterns of practice and …

Background Glucosamine and chondroitin sulfate are used to treat osteoarthritis. The
multicenter, double-blind, placebo- and celecoxib-controlled Glucosamine/chondroitin Arthritis …

Background Rheumatoid arthritis is a common disease that causes substantial morbidity and
mortality. The responses of patients with rheumatoid arthritis to treatment with a single so-…

A better understanding of the pathophysiology of rheumatoid arthritis, together with
influential trials aimed at treating early stages of the disease, has altered therapy. This article …

Kelley's Textbook of Rheumatology delivers the state-of-the-art scientific and clinical know-how
you need to offer your patients the most effective diagnosis and care. This rheumatology …

Objective To assess whether it is better to intensively treat all patients with early rheumatoid
arthritis (RA) using combinations of drugs or to reserve this approach for patients who do not …

Background Few blinded trials have compared conventional therapy consisting of a
combination of disease-modifying antirheumatic drugs with biologic agents in patients with …